Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Voyager Therapeutics (VYGR) Tax Provisions: 2016-2024

Historic Tax Provisions for Voyager Therapeutics (VYGR) over the last 5 years, with Dec 2024 value amounting to $665,000.

  • Voyager Therapeutics' Tax Provisions rose 93.02% to $83,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $719,000, marking a year-over-year decrease of 20.38%. This contributed to the annual value of $665,000 for FY2024, which is 52.77% down from last year.
  • Latest data reveals that Voyager Therapeutics reported Tax Provisions of $665,000 as of FY2024, which was down 52.77% from $1.4 million recorded in FY2023.
  • Voyager Therapeutics' 5-year Tax Provisions high stood at $1.4 million for FY2023, and its period low was $16,000 during FY2022.
  • Its 3-year average for Tax Provisions is $696,333, with a median of $665,000 in 2024.
  • As far as peak fluctuations go, Voyager Therapeutics' Tax Provisions soared by 8,700.00% in 2023, and later slumped by 52.77% in 2024.
  • Yearly analysis of 3 years shows Voyager Therapeutics' Tax Provisions stood at $16,000 in 2022, then soared by 8,700.00% to $1.4 million in 2023, then crashed by 52.77% to $665,000 in 2024.